Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Humana    HUM

HUMANA (HUM)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.69 for the 2017 fiscal year.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The stock is in a well-established, long-term rising trend above the technical support level at 245 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 284.57.
  • Technically, the stock approaches a strong medium-term resistance at USD 301.67.
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's earnings releases usually do not meet expectations.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Sector Managed Healthcare - NEC
1st jan.Capitalisation (M$)Investor Rating
HUMANA12.59%39 901
UNITEDHEALTH GROUP10.38%235 285
ANTHEM INC11.13%64 206
AETNA4.11%61 242
CIGNA8.40%54 278
CENTENE CORPORATION9.70%19 098
WELLCARE HEALTH PLANS, INC.8.79%9 741
MOLINA HEALTHCARE, INC.19.76%5 243
MAGELLAN HEALTH INC4.40%2 423
More Results
Financials ($)
Sales 2017 53 570 M
EBIT 2017 3 357 M
Net income 2017 2 555 M
Finance 2017 2 879 M
Yield 2017 0,53%
P/E ratio 2017 15,95
P/E ratio 2018 21,62
EV / Sales 2017 0,69x
EV / Sales 2018 0,65x
Capitalization 39 901 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart HUMANA
Duration : Period : Day
Humana Technical Analysis Chart | HUM | US4448591028 | 4-Traders
Duration : Period : Week
Humana Technical Analysis Chart | HUM | US4448591028 | 4-Traders